Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7

Dominik Nörz, Moritz Grunwald, Flaminia Olearo, Nicole Fischer, Martin Aepfelbacher, Susanne Pfefferle, Marc Lütgehetmann
doi: https://doi.org/10.1101/2021.02.12.21251614

Article usage

Article usage: February 2021 to November 2024

AbstractFullPdf
Feb 202148825168
Mar 202119799167
Apr 20211073966
May 20211072670
Jun 2021731537
Jul 202150815
Aug 2021391217
Sep 2021521229
Oct 202158338
Nov 202138624
Dec 202136616
Jan 2022291014
Feb 2022152610
Mar 20221649
Apr 202223211
May 202211212
Jun 202222372
Jul 202219159
Aug 20222639
Sep 202237011
Oct 20222817
Nov 20221423
Dec 20221919
Jan 202315011
Feb 20231245
Mar 20231243
Apr 20232024
May 2023924
Jun 20231145
Jul 20231012
Aug 202314116
Sep 20231165
Oct 20231003
Nov 20231893
Dec 20231002
Jan 2024703
Feb 20241222
Mar 20241153
Apr 202413410
May 2024847
Jun 20241588
Jul 2024747
Aug 202412212
Sep 20242669
Oct 2024944
Nov 2024103
Back to top
Posted February 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7
Dominik Nörz, Moritz Grunwald, Flaminia Olearo, Nicole Fischer, Martin Aepfelbacher, Susanne Pfefferle, Marc Lütgehetmann
medRxiv 2021.02.12.21251614; doi: https://doi.org/10.1101/2021.02.12.21251614
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area